Mary Oates, PhD Sanofi

Dr. Mary Oates has 30 years of biopharmaceutical experience in Quality, Manufacturing Operations and Regulatory Affairs. She is currently SVP and Head, Vaccines Industrial Affairs at Sanofi. Prior to this, she spent 25 years at Pfizer, holding multiple senior leadership roles. In Operations, she was responsible for the Biotechnology and Consumer manufacturing plants and operational excellence for the entire manufacturing division. Dr. Oates was also the Global Quality Operations leader at Pfizer for 8 years, with responsibility for quality oversight of all GMP activities. She has also held positions at Glaxo and Lachman Consultant Services.

Dr. Oates currently serves on the Board of Directors of the Parenteral Drug Association and was a member of the ICH Expert Working Group for Q12, a Quality Guideline on Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. She also led or contributed to numerous Pharmaceutical Research and Manufacturers of America working groups through her career.

Dr. Oates holds an undergraduate degree in Biochemistry from Queens College and a Ph.D. in Analytical Chemistry from the University of North Carolina in Chapel Hill.